Photo: Courtesy of Samsung
LAS VEGAS – At the 2026 HIMSS Global Health Conference & Exposition here, Samsung Electronics America announced a partnership with Verily Life Sciences to connect Verily's precision health platform, Pre, with Samsung's Galaxy Watch8 to monitor real-world populations and generate evidence to assist in research for life sciences and governments.
Pre is an AI-enabled offering that processes structured and unstructured multimodal data for AI deployment, workflow orchestration and analytics.
The partnership will integrate sensor data from the Galaxy Watch and make it accessible in its Viewpoint Evidence tool, built on the company's Pre platform.
"Sponsors will use Verily Pre data solutions including Refinery for data harmonization and Workbench for analysis, modeling and activation. Verily will provide AI/ML-based analytics and digital measure expertise, paired with comprehensive clinical trial support across regulatory, development, operations and compliance," Verily said in a statement.
The companies aim to help life sciences organizations and governments accelerate research using health analytics and customer-grade wearable data.
The partners say the collaboration will allow researchers to combine Verily's longitudinal datasets from consented participants with Samsung's data, customize research capabilities by allowing sponsors to run their own studies, and recruit and engage Samsung users for research participation.
As part of the collaboration, the partners said they will further explore jointly developing new solutions for clinical research.
